Assessing the performance of different outcomes for tumor growth studies with animal models-Reference-Cited by-同舟云学术

Assessing the performance of different outcomes for tumor growth studies with animal models

Published:2022-06 Issue:3 Volume:5 Page:248-257
ISSN:2576-2095
Container-title:Animal Models and Experimental Medicine
language:en
Short-container-title:Anim Models and Exp Med

Author:

Patten Luke W.¹,Blatchford Patrick¹,Strand Matthew¹,Kaizer Alexander M.¹^ORCID

Affiliation:

1. Department of Biostatistics and Informatics University of Colorado Aurora Colorado USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Automotive Engineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ame2.12250

Reference22 articles.

1. Patient-derived tumour xenografts as models for oncology drug development

2. Development and maintenance of a preclinical patient derived tumor xenograft model for the investigation of novel anti‐cancer therapies;Bagby S;J Vis Exp,2016

3. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance

4. Patient-derived xenograft (PDX) models, applications and challenges in cancer research

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of chicken chorioallantoic membrane model for tumor imaging and drug development: Promising findings;Animal Models and Experimental Medicine;2024-01-17

2. Focused ultrasound ablation of melanoma with boiling histotripsy yields abscopal tumor control and antigen-dependent dendritic cell activation;Theranostics;2024

3. Cellular and molecular characteristics of the premetastatic niches;Animal Models and Experimental Medicine;2023-10

4. Focused ultrasound ablation of melanoma with boiling histotripsy yields abscopal tumor control and antigen-dependent dendritic cell activation;2023-09-06